Lilly, Roche to get expedited FDA review for Alzheimer’s diagnostic test
A new blood test being developed through a collaboration between Roche Diagnostics and Eli Lilly and Co. has been granted a breakthrough device designation by the U.S. Food and Drug Administration. The designation is intended to speed development and...... Read More